Merck executives will conduct a live sales and earnings conference call for its investors and analysts at 8 a.m. Oct. 27.
This call, which will provide an overall perspective on company performance for the year’s third quarter, will be open to stakeholders and the general public, including the press, according to an announcement.
Additionally, a webcast will be available for replay in conjunction with sales and earnings details and auxiliary financial information.
Institutional investors and analysts can participate in the call by dialing 706-758-9927 or 877-381-5782 and using ID code 83569475. Members of the media can monitor the call by dialing 706-758-9928 or 800-399-7917 and using ID code 83569475. Additionally, members of the media with questions are asked to contact any member of Merck’s media-relations team after the call.
Merck focuses on prescription medications, vaccines, biologic therapies and products for animal health. It researches solutions for life-threatening diseases including cancer, cardio-metabolic conditions, animal diseases, Alzheimer’s and infectious diseases such as HIV and Ebola.
